Subjective Cognitive Decline (scd) Clinical Trials
3 recruiting trials for Subjective Cognitive Decline (scd). Eligibility criteria explained in plain English.
TrialFinderData lists 3 Subjective Cognitive Decline (scd) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Stichting International Registry for Alzheimer's Disease and other Dementias Foundation (1), University of Bern (1), University of Milano Bicocca (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is None, this is a non-interventional observational study (other, 1 trial), followed by Phase-locked auditory stimulation (PLAS), Sham Phase-Locked Auditory Stimulation.
Track Subjective Cognitive Decline (scd) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
InRAD Observational Study
The goal of this international observational study is to evaluate long-term disease outcomes and treatment safety in people with Alzheimer's disease (PwAD), by collecting...
Effects of Real vs. Soundless Acoustic Stimulation During Deep Sleep on Brain Activity, Memory, and Blood Biomarkers in...
This study aims to explore a non-invasive way to improve memory and slow cognitive decline in older adults by enhancing sleep quality. Dementia, a leading cause of death...
Lombard Cohort of Brain Health Services
The goal of this multicenter prospective observational cohort study is to better understand the clinical, neuropsychological, and biological characteristics of individuals...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Subjective Cognitive Decline (scd), with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Subjective Cognitive Decline (scd), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Subjective Cognitive Decline (scd), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.